fbpx
EVENTS|NEWS|CONTACT|DONATE
Read Our Newsletter

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
Janus kinase 1 protein
Dec 04 2019

Elevar Announces Results from the Angel Trial, A Study of Monotherapy Rivoceranib (Apatinib) In Late-Stage Gastric Cancer Patients

At ESMO 2019, Elevar Therapeutics announced that in a phase 3 trial in gastric cancer patients, rivoceranib did not improve overall survival but did nearly double progression-free survival.

Read Source
, ,

Social Media

   

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Please join with us to fuel the next wave of progress.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.
Please join with us to fuel the next wave of progress. Support our 2024 Fundraising Campaign.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Together, we will defeat stomach cancer.

Together, we will defeat stomach cancer.

MORE INFODONATE
X